Evidence map›Paper›PMID 38304555›Full record

ArticleClinical & translational immunology2024

SARS-CoV-2-associated T-cell infiltration in the central nervous system.

Malte Mohme, Christoph Schultheiß, Andras Piffko, Antonia Fitzek, Lisa Paschold, Benjamin Thiele, Klaus Püschel, Markus Glatzel, Manfred Westphal, Katrin Lamszus and 2 more

Open access · goldAbstract read
In one paragraph

Article in Clinical & translational immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Human brain matters: Navigating the neuropathology of COVID-19.Brain pathology (Zurich, Switzerland) · 2026
    Review
  2. Review
  3. Neuroimmune pathophysiology of long COVID.Psychiatry and clinical neurosciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Malte MohmeDepartment of Neurosurgery University Medical Centre Hamburg-Eppendorf Hamburg Germany.ORCID https://orcid.org/0000-0003-0627-9092
Christoph SchultheißMedical Oncology University Hospital Basel Basel Switzerland.
Andras PiffkoDepartment of Neurosurgery University Medical Centre Hamburg-Eppendorf Hamburg Germany.
Antonia FitzekDepartment of Legal Medicine University Medical Centre Hamburg-Eppendorf Hamburg Germany.
Lisa PascholdInternal Medicine IV, Oncology/Hematology Martin-Luther-University Halle-Wittenberg Halle (Saale) Germany.
Benjamin ThieleMedical Oncology University Hospital Basel Basel Switzerland.
Klaus PüschelDepartment of Legal Medicine University Medical Centre Hamburg-Eppendorf Hamburg Germany.
Markus GlatzelInstitute of Neuropathology University Medical Centre Hamburg-Eppendorf Hamburg Germany.
Manfred WestphalDepartment of Neurosurgery University Medical Centre Hamburg-Eppendorf Hamburg Germany.
Katrin LamszusDepartment of Neurosurgery University Medical Centre Hamburg-Eppendorf Hamburg Germany.
Jakob MatschkeInstitute of Neuropathology University Medical Centre Hamburg-Eppendorf Hamburg Germany.
Mascha BinderMedical Oncology University Hospital Basel Basel Switzerland.
Universität Hamburg · DEUniversity of Basel · CHMartin Luther University Halle-Wittenberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). Although an acute SARS-CoV-2 infection mainly presents with respiratory illness, neurologic symptoms and sequelae are increasingly recognised in the long-term treatment of COVID-19 patients. The pathophysiology and the neuropathogenesis behind neurologic complications of COVID-19 remain poorly understood, but mounting evidence points to endothelial dysfunction either directly caused by viral infection or indirectly by inflammatory cytokines, followed by a local immune response that may include virus-specific T cells. However, the type and role of central nervous system-infiltrating T cells in COVID-19 are complex and not fully understood. Methods: We analysed distinct anatomical brain regions of patients who had deceased as a result of COVID-19-associated pneumonia or complications thereof and performed T cell receptor Vβ repertoire sequencing. Clonotypes were analysed for SARS-CoV-2 association using public TCR repertoire data. Results: Our descriptive study demonstrates that SARS-CoV-2-associated T cells are found in almost all brain areas of patients with fatal COVID-19 courses. The olfactory bulb, medulla and cerebellum were brain regions showing the most SARS-CoV-2 specific sequence patterns. Neuropathological workup demonstrated primary CD8 Conclusion: Future research is needed to better define the relationship between T-cell infiltration and neurological symptoms and its long-term impact on patients' cognitive and mental health.

Indexed as

central nervous systemCOVID‐19COVID‐19‐specific T cellneuroinflammationSARS‐CoV‐2TCR sequencing

Identifiers

PMID38304555
PMCPMC10831126
OpenAlexW4391452593

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.